The study, dubbed TACTI-004, will focus on first line NSCLC patients with a tumour proportion score (TPS) PD-L1 of greater than one per cent, as Efti has already received fast track designation for low TPS scores.” The
The study, dubbed TACTI-004, will focus on first line NSCLC...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.010(2.33%) |
Mkt cap ! $499.3M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 42.5¢ | 41.0¢ | $774.2K | 1.850M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 64086 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 8523 | 2 |
View Market Depth
| Last trade - 16.10pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
42.5¢ |
Change
-0.010 ( 2.30 %) |
||||
| Open | High | Low | Volume | ||
| 42.0¢ | 42.5¢ | 41.5¢ | 370763 | ||
| Last updated 15.59pm 01/05/2024 ? | |||||
| IMM (ASX) Chart |